UW18110
OPEN TO ACCRUAL
P I study OAR based dose escalated SBRT w/ real time adaptive MRI guidance liver mets
NCI10608
OPEN TO ACCRUAL
PII Durvalumab w/ Gem + Cis as Neoadjuvant therapy for high risk resectable intrahepatic cholangio
UW24147
OPEN TO ACCRUAL
Ph 2 Study of Casdozokitug w/Toripalimab + Bevacizumab in Participants With Hepatocellular Carcinoma